IMW 2019 | Accelerating drug approval with better metrics in myeloma

Nicole Gormley

Nicole Gormley, MD, FDA, Silver Spring, MD, discusses how better metrics can accelerate drug approval in multiple myeloma at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  
Similar topics